Weekly News – October 27
Thank you for making the CRC Allocators Conference a Success
WeWork battles looming
Barclays takes on double-dips
This is phenomenal content analyzing the latest wave of LME transactions
Is the double dip here to stay?
FAs start your pitching…
No need to thank us.
Just sponsor our curated content!
Make Wholes & Hertz
Air Methods files for BK
Crypto bull run
Genesis going it alone
Purdue briefing complete
Oral argument scheduled for December 4, 2023
Find the briefs here
A potent debt mixture is brewing…
Leading to some cracks in credit
CRC Allocators Conference
This event is available to institutional investors only
Featured Event: Beard Investing Conference
CRC weighs in on Serta
The Academics Speak Up
Purdue Pharma is the gift that keeps on giving. This is our third installment on the twists and turns this case has taken through the Courts. You can read our first installment here, and our second here.
All bets came off the table when the Supreme Court decided to reshuffle the deck by taking on the appeal of the 2nd Circuit’s decision. Not only did SCOTUS take the unusual step of taking on this big ticket issue in BK cases but it also stopped the lower court’s decision in its tracks putting the breaks on the entire enchilada. We decided to consult with our expert Academic Contributors for our inaugural feature the Academics Speak Up to get their takes on the latest developments.
We are excited to bring you the varying perspectives of Prof. Tony Casey, Prof. Samir Parikh and Prof. Ralph Brubaker.
Read more on Purdue Pharma
click through to read the features from our Contributors
Read our recent coverage:
Where Are We In The Credit Cycle?
Look out for more great features from our Contributors
Have something interesting to share?
email us at [email protected]